secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001753926-23-001017
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella raises CEO and CMO salaries by $50k each
------------------------------------------------

- CEO Jonathan Kaufman annual base salary increased by $50,000 to $233,300 effective August 4, 2023.
- CMO Michael Chancellor annual base salary increased by $50,000 to $225,000 effective August 4, 2023.
- Both amendments executed on August 4, 2023; all other terms of existing employment agreements remain unchanged.
- The salary increases are reflected in amendments to employment agreements originally dated July 17, 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/0001753926-23-001017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/g083697_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer